Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quest Diagnostics Inc (DGX) vs AT&T Inc. (T) Price & Performance

Quest Diagnostics IncTrade

Price performance (Past 24H)

Key statistics

Quest Diagnostics Inc vs AT&T Inc. — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while AT&T Inc. trades at $24.44 (market cap $167.88B). The key difference: AT&T Inc. is far larger — about 6.4× Quest Diagnostics Inc's market cap, and AT&T Inc. pays the higher dividend (4.53%). Which is the better fit depends on your goals.

DGXT
Market Cap
$26.21B$167.88B
Sector
HealthMedia
52-Week High
$238.50$29.62
52-Week Low
$173.49$20.49
Enterprise Value
$31.97B$313.20B
Dividend Yield
1.45%4.53%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX

About AT&T Inc.

AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.

Read more on T